NXN-188 Completed Phase 2 Trials for Migraine Without Aura Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00959751Study of the Safety and Effectiveness of NXN-188 for the Treatment of Migraine Headache Without Aura